<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html><!-- #BeginTemplate "/Templates/basic.dwt" --><!-- DW6 -->

<head>
<!-- #BeginEditable "doctitle" --> 
<title>11-20 ionic minerals selenium dietary supplement research. nutritional 
supplement research.</title>
<meta name="artdescription" content="Dietary supplement, nutritional supplement, diet supplement all selenium research. ionic minerals - selenium mineral supplement and nutrition effects.">
<meta name="artkeywords" content="ionic minerals,ionic minerals selenium,dietary supplement,nutritional supplement,diet supplement,mineral supplement,selenium research, selenium and prostate cancer">
<meta name="artrobots" content="index,follow">
<!-- #EndEditable -->
<link rel="stylesheet" href="../../css/maincss.css" type="text/css">
<SCRIPT LANGUAGE="JavaScript" TYPE="text/javascript" SRC="../../javascript/menufirst2.js"></SCRIPT>
</head>

<body link="#0000FF" vlink="#800080" background="../../images/testbck9.gif">

<table border="0" cellpadding="0" width="100%" height="100%" align="center" cellspacing="0">
  <tr>
  <td width="140" height="1" align="center">
    <td valign="top" rowspan="2"><div align="left"><left><table border="0" width="530">
      <tr>
              <td valign="top" align="center" width="100%"><!-- #BeginLibraryItem "/Library/logo_general.lbi" --><p align="center"><img src="../../images/newlogo1.gif" alt="colloidal silver, ionic minerals, MSM, methylsufonylmethane, trace minerals, msm, colloidal silver generator, essential minerals, structured water, natural pet products, alternative health, arthritis pain relief, water filters, mineral supplements, glucosamine, chondroitin" border="0" align="center" width="455" height="60"></p>
<!--#include virtual="/ssi/logo_nature_header.html" --><!-- #EndLibraryItem --><blockquote> <!-- #BeginEditable "content" --> 
                <h3 align="center" class="fonts"><u>Research on the Mineral Selenium</u></h3>
                <p align="left" class="mainfont">The following research abstracts 
                  are presented to reflect the findings of possible benefits from 
                  minerals as a dietary supplement and nutritional supplement. 
                  You will find more on the <a href="../../minerals/selenium.html">ionic 
                  selenium</a> page.</p>
                <h4 align="center" class="fonts"><a name="artart11"><font color="#0000AA">Assessment 
                  of selenium and vitamin E deficiencies in dairy herds and clinical 
                  disease in calves.</font></a></h4>
                <p align="left" class="mainfont">Vet Rec (ENGLAND) Oct 19 1996, 
                  139 (16) p391-4</p>
                <p align="left" class="mainfont">Because of the very low concentrations 
                  of <font color="#0088AA">selenium</font> in the dry matter of 
                  grass, grass silage, hay and maize silage Slovenian dairy herds 
                  need to be supplemented with <font color="#0088AA">selenium</font>. 
                  Selenium in the form of mineral and feed mixtures maintained 
                  adequate mean (sd) blood serum <font color="#0088AA">selenium</font> 
                  concentrations of 43.9 (27.6) to 65.3 (18.5) micrograms/litre 
                  in lactating cows, but in late lactation and in the dry period 
                  when only mineral mixtures were used, about 60 per cent of the 
                  cows had marginal serum <font color="#0088AA">selenium</font> 
                  concentrations, mainly because of the low intake of the mineral 
                  supplement. In 18 herds which were either unsupplemented or 
                  irregularly supplemented with <font color="#0088AA">selenium</font>, 
                  the mean (sd) concentrations in blood serum were 13.7 (5.5) 
                  micrograms/litre and 17.4 (9.2) micrograms/litre, respectively, 
                  for <font color="#0088AA">selenium</font> and 2.98 (2.72) mg/litre 
                  and 1.62 (1.73) mg/litre for vitamin E, indicating that under 
                  extensive farming conditions in Slovenia the lack of both micronutrients 
                  may be responsible for nutritional muscular dystrophy in calves. 
                  Among 37 clinical cases, cardiorespiratory signs predominated 
                  in 25 of the calves and skeletal myopathy was dominant in 12. 
                  A very low mean serum <font color="#0088AA">selenium</font> 
                  concentration [9.7 (7.2) micrograms/litre] and typically high 
                  activities of aspartate aminotransferase (AST) [1125 (373) U/litre] 
                  and creatine kinase (CK) [9169 (3681) U/litre) were observed 
                  for the myocardial form of the disease, and 2797 (550) U/litre 
                  and 22,650 (13,500) U/litre were observed for the skeletal form 
                  of the disease. A highly significant (P &lt;0.0001) difference 
                  in the <font color="#0088AA">selenium</font> concentration of 
                  liver dry matter between the regularly supplemented [402 (207) 
                  micrograms/kg] and irregularly supplemented [173 (69) micrograms/kg] 
                  herds was observed. If a minimum value of 300 micrograms/kg 
                  of liver dry matter is accepted as the criterion for the determination 
                  of adequate <font color="#0088AA">selenium</font> status, 93 
                  per cent of the samples from the irregularly supplemented herds 
                  were <font color="#0088AA">selenium</font> deficient. A similar 
                  proportion was estimated to be <font color="#0088AA">selenium</font> 
                  deficient when the criterion was taken to be 30 micrograms <font color="#0088AA">selenium</font>/litre 
                  of blood serum.</p>
                <p align="center" class="mainc"><a href="./"><img src="../../images/back.gif" border="0" width="42" height="10"></a></p>
                <h4 align="center" class="fonts"><a name="art12"><font color="#0000AA">Aortic 
                  and iliac artery thrombosis in calves: nine cases (1974-1993)</font></a></h4>
                <p align="left" class="mainfont">J Am Vet Med Assoc (UNITED STATES) 
                  Jul 1 1996, 209 (1) p130-6</p>
                <p align="left" class="mainfont">OBJECTIVE--To identify common 
                  clinical and diagnostic features of calves with aortic or iliac 
                  artery thrombosis that might aid in antemortem diagnosis of 
                  this condition. DESIGN--Retrospective case series. ANIMALS--9 
                  calves or months old in which aortic or iliac artery thrombosis 
                  was confirmed at necropsy. RESULTS--All calves had an acute 
                  onset of paresis or flaccid paralysis of 1 or both hind limbs. 
                  Affected limbs were hypothermic and had diminished spinal reflexes 
                  and diminished pulse pressures. Diagnosis was definitively established 
                  in 2 calves by use of angiography. All 9 calves died or were 
                  euthanatized. CLINICAL IMPLICATIONS--This condition is rare 
                  and could be mistaken for more common diseases of young cattle, 
                  such as traumatic injury of the axial or appendicular skeleton, 
                  vertebral osteomyelitis, nutritional muscular dystrophy associated 
                  with vitamin E or <font color="#0088AA">selenium</font> deficiency, 
                  injury to the sciatic or femoral nerves, or clostridial myositis.</p>
                <p align="center" class="mainc"><a href="./"><img src="../../images/back.gif" border="0" width="42" height="10"></a></p>
                <h4 align="center" class="fonts"><a name="art13"><font color="#0000AA">[Selenium 
                  concentration in blood and Duchenne-type progressive muscular 
                  dystrophy]</font></a></h4>
                <p align="left" class="mainfont">Nippon Rinsho (JAPAN) Jan 1996, 
                  54 (1) p134-40</p>
                <p align="left" class="mainfont">The concentration of <font color="#0088AA">selenium</font> 
                  (Se) and the activity of glutathione peroxidase (GSH-Px) in 
                  plasma and erythrocytes were measured in healthy men and in 
                  patients with Duchenne-type progressive muscular dystrophy (DMD). 
                  In healthy men, the Se concentration in erythrocytes showed 
                  a steep rise with aging and ascended gradually in plasma. The 
                  GSH-Px activity in both plasma and erythrocytes clearly increased 
                  with aging. The relationship between the Se concentration and 
                  the GSH-Px activity in healthy men showed a parallel rise with 
                  aging, but the coefficients of correlation were not very high 
                  (r = 0.44 and 0.56 in plasma and erythrocytes, respectively. 
                  In DMD patients, on the other hand, the Se concentration in 
                  erythrocytes decreased steeply with aging, and it decreased 
                  gradually in plasma. The GSH-Px activity in both plasma and 
                  erythrocytes apparently increased as in healthy men with aging, 
                  but the level was about 80% of that of healthy men. When selenite 
                  (Se+4) is added to the whole blood in vitro at 25 degrees C, 
                  it is rapidly taken up by erythrocytes (within several minutes) 
                  and is then released into plasma (a period of 30 min), then 
                  subsequent reuptake by erythrocytes is proceeded slowly. Our 
                  attention was attracted to the pattern of selenite release from 
                  erythrocytes of DMD patients.</p>
                <p align="center" class="mainc"><a href="./"><img src="../../images/back.gif" border="0" width="42" height="10"></a></p>
                <h4 align="center" class="fonts"><a name="art14"><font color="#0000AA">Antioxidant 
                  status and neovascular age-related macular degeneration</font></a></h4>
                <p align="left" class="mainfont">ARCH. OPHTHALMOL. (USA), 1993, 
                  111/1 (104-109)</p>
                <p align="left" class="mainfont">We evaluated the hypothesis that 
                  higher serum levels of micronutrients with antioxidant capabilities 
                  may be associated with a decreased risk of neovascular age-related 
                  macular degeneration by comparing serum levels of carotenoids, 
                  vitamins C and E, and <font color="#0088AA">selenium</font> 
                  in 421 patients with neovascular age-related macular degeneration 
                  and 615 controls. Subjects were classified by blood level of 
                  the micronutrient (low, medium, and high). Persons with carotenoid 
                  levels in the medium and high groups, compared with those in 
                  the low group, had markedly reduced risks of neovascular age-related 
                  macular degeneration, with levels of risk reduced to one half 
                  and one third, respectively. Although no statistically significant 
                  protective effect was found for vitamin C or E or <font color="#0088AA">selenium</font> 
                  individually, an antioxidant that combined all four micronutrient 
                  measurements showed statistically significant reductions of 
                  risk with increasing levels of the . Although these results 
                  suggest that higher blood levels of micronutrients with antioxidant 
                  potential, in particular, carotenoids, may be associated with 
                  a decreased risk of the most visually disabling form of age-related 
                  macular degeneration, it would be premature to translate these 
                  findings into nutritional recommendations.</p>
                <p align="center" class="mainc"><a href="./"><img src="../../images/back.gif" border="0" width="42" height="10"></a></p>
                <h4 align="center" class="fonts"><a name="art15"><font color="#0000AA">Effects 
                  of hepatic stimulator substance, herbal medicine, selenium/vitamin 
                  E, and ciprofloxacin on cirrhosis in the rat</font></a></h4>
                <p align="left" class="mainfont">Gastroenterology (USA), 1996, 
                  110/4 (1150-1155)</p>
                <p align="left" class="mainfont">Background and Aims: Cirrhosis 
                  is a potentially lethal condition for which there is no proven 
                  effective therapy. The aim of this study was to compare the 
                  effects of hepatic stimulator substance, traditional Chinese 
                  herbal medicine, <font color="#0088AA">selenium</font> plus 
                  vitamin E, and ciprofloxacin treatment on biochemical and histological 
                  features of fibrosis in rats with carbon tetrachloride (CCl4)/ethanol-induced 
                  cirrhosis. Methods: One hundred twenty adult Wistar rats were 
                  divided into six study groups (20 rats/group): healthy controls, 
                  CCl4/ethanol-injured rats left untreated, and CCl4/ethanol-injured 
                  rats treated for 4 weeks with either hepatic stimulator substance, 
                  traditional Chinese herbal medicine, a combination of <font color="#0088AA">selenium</font> 
                  plus vitamin E, or ciprofloxacin. After the 4-week treatment, 
                  rats were killed and the following parameters of hepatic fibrosis 
                  were determined: hepatic hydroxyproline and proline levels, 
                  serum hyaluronic acid concentrations, and histological staining 
                  of hepatic tissue. Results: Hepatic fibrosis was significantly 
                  improved in all four treated groups compared with the untreated 
                  CCl4/ethanol-injured controls. Improvements were most striking 
                  in the groups treated with traditional Chinese herbal medicine 
                  and ciprofloxacin. Conclusions: The data indicate that hepatic 
                  stimulator substance, traditional Chinese herbal medicine, <font color="#0088AA">selenium</font> 
                  plus vitamin E, and ciprofloxacin significantly decrease the 
                  amount of hepatic fibrosis caused by CCl4/ethanol injury in 
                  rats.</p>
                <p align="center" class="mainc"><a href="./"><img src="../../images/back.gif" border="0" width="42" height="10"></a></p>
                <h4 align="center" class="fonts"><a name="art16"><font color="#0000AA">Induction 
                  of renal damage in rats by a diet deficient in antioxidants</font></a></h4>
                <p align="left" class="mainfont">Nutrition Research (USA), 1996, 
                  16/9 (1607-1612)</p>
                <p align="left" class="mainfont">Male albino rats, age 28 days, 
                  were fed a diet containing both vitamin E (10 g/kg) and <font color="#0088AA">selenium</font> 
                  (5 mg/kg) or a diet lacking these antioxidants. Animals were 
                  examined for renal function after 4, 8, 12 and 16 wk on the 
                  respective diets. After 8 wk, animals on the deficient diet 
                  weighed less than controls (15%, P &lt;0.01), and this became 
                  more pronounced by 16 weeks (25%, P &lt;0.01). Expressed on 
                  a body weight basis, kidney wet weights did not differ between 
                  the two groups of animals. Urine volume increased in the animals 
                  fed the deficient diet at 8 weeks (66%, P &lt;0.01) and this 
                  was maintained at 16 weeks (35%, P &lt;0.01). Similar increases 
                  were observed for the rates of excretion of urinary total protein 
                  (77% elevation at 16 wk, P &lt;0.01) and urinary acid phosphatase 
                  (51% elevation, P &lt;0.01). At 16 wk, the specific activity 
                  of renal acid phosphatase in the animals given the deficient 
                  diet was reduced in cortex (57%, P &lt;0.01) and medulla (20%, 
                  P &lt;0.01), but not in papilla. These data indicate that dietary 
                  antioxidant deficiency causes progressive and pronounced renal 
                  damage.</p>
                <p align="center" class="mainc"><a href="./"><img src="../../images/back.gif" border="0" width="42" height="10"></a></p>
                <h4 align="center" class="fonts"><a name="art17"><font color="#0000AA">Sudden 
                  infant death syndrome (SIDS): oxygen utilization and energy 
                  production.</font></a></h4>
                <p align="left" class="mainfont">Med Hypotheses (ENGLAND) Jun 
                  1993, 40 (6) p364-6</p>
                <p align="left" class="mainfont">Reid found <font color="#0088AA">selenium</font> 
                  (Se) deficient soils were a common factor in two populations 
                  with the highest incidence of SIDS world-wide (Indian population 
                  of King County Washington State, USA and the population of Canterbury, 
                  New Zealand). Reid compared a map of the <font color="#0088AA">selenium</font> 
                  responsive livestock areas in New Zealand with areas of low 
                  soil iodine (I). She found that the 1989 report of areas of 
                  the highest SIDS incidence coincided with Se responsive livestock 
                  areas combined with low soil iodine. Foster found the 1983-84 
                  incidence of SIDS in USA has the strongest positive correlation 
                  with the incidence of goitre in World War I troops (1916). Sodium 
                  and strontium were positively related. Emery found a hypernatraemic 
                  SIDS victim in a very cold environment. Robertson and Parker 
                  associated increased sodium (Na) (used in Scunthorpe, England, 
                  as a water softener) with increased incidence of SIDS. Godwin's 
                  study of White Muscle Disease in lambs describes Se protection. 
                  Skeletal muscle mitochondria from dystrophic animals showed 
                  lowered respiratory rates with palmitoyl-dl-carnitine and acetyl-dl-carnitine 
                  as substrate. Dystrophic organelles failed to respond to ADP. 
                  Rognun found elevated hypoxanthine and an enhanced immune response 
                  in most SIDS victims. A syndrome associated with potassium deficiency 
                  has been described as a killer of healthy, young Asian men, 
                  most often during sleep. This paper describes the interactions 
                  of sodium (Na), potassium (K), <font color="#0088AA">selenium</font> 
                  (Se), and iodine (I) to some factors affecting the utilization 
                  of oxygen and the production of energy. (19 Refs.)</p>
                <p align="center" class="mainc"><a href="./"><img src="../../images/back.gif" border="0" width="42" height="10"></a></p>
                <h4 align="center" class="fonts"><a name="art18"><font color="#0000AA">Prospects 
                  for nutritional control of hypertension </font></a></h4>
                <p align="left" class="mainfont">Med Hypotheses (ENGLAND) Mar 
                  1981, 7 (3) p271-83</p>
                <p align="left" class="mainfont">Sodium restriction is not the 
                  only nutritional measure likely to prove valuable in the treatment 
                  and prevention of hypertension. The hypotensive effects of central 
                  adrenergic stimulation can be promoted by supplementary tyrosine, 
                  insulin potentiation (as with GTF), and (possibly) high-dose 
                  pyridoxine. Insulin potentiators (GTF) and prostaglandin precursors 
                  (essential fatty acids) should have direct relaxant effects 
                  on vascular muscle. A high potassium, low sodium diet, coenzyme 
                  Q, and prevention of cadmium toxicity (as with dietary <font color="#0088AA">selenium</font>) 
                  may act to offset renally-mediated pressor influences. Functional 
                  combinations of these measures might prove to be substantially 
                  effective, in which case they would offer considerable advantages 
                  over potentially toxic drug therapies.</p>
                <p align="center" class="mainc"><a href="./"><img src="../../images/back.gif" border="0" width="42" height="10"></a></p>
                <h4 align="center" class="fonts"><a name="art19"><font color="#0000AA">The 
                  decline in stroke mortality. An epidemiologic perspective</font></a></h4>
                <p align="left" class="mainfont">Ann Epidemiol (UNITED STATES) 
                  Sep 1993, 3 (5) p571-5</p>
                <p align="left" class="mainfont">The evidence that treatment of 
                  hypertension prevents stroke is incontrovertible. Several observations, 
                  however, suggest that improvements in the prevalence of antihypertensive 
                  treatment cannot explain all of the recent decline in stroke 
                  mortality. Changes in nutritional patterns may explain some 
                  of the observed decline. Prospective studies have demonstrated 
                  conclusively an independent, increasing risk of hemorrhagic, 
                  but not thrombotic, stroke at higher levels of alcohol use. 
                  Stroke mortality is associated inversely with fat and protein 
                  intake. Dietary sodium has been linked to stroke in ecologic 
                  studies but not in prospective studies. Ecologic studies have 
                  suggested that foods high in vitamin C and potassium protect 
                  against stroke; an inverse association of potassium intake with 
                  fatal stroke has been demonstrated in cohort studies. Two studies 
                  in humans also suggest a protective effect of serum <font color="#0088AA">selenium</font> 
                  against subsequent stroke. Determination of the influence of 
                  nutrients on stroke incidence offers tantalizing opportunities 
                  for future research and possibly, intervention.</p>
                <p align="center" class="mainc"><a href="./"><img src="../../images/back.gif" border="0" width="42" height="10"></a></p>
                <h4 align="center" class="fonts"><a name="art20"><font color="#0000AA">Serum 
                  selenium, plasma glutathione (GSH) and erythrocyte glutathione 
                  peroxidase GSH-Px)-levels in asymptomatic versus symptomatic 
                  human immunodeficiency virus-1 (HIV-1)-infection</font></a></h4>
                <p align="left" class="mainfont">European Journal of Clinical 
                  Nutrition (United Kingdom), 1997, 51/4 (266-272)</p>
                <p align="left" class="mainfont">Objectives: Antioxidant defense 
                  status was investigated in HIV-infected patients by measuring 
                  serum <font color="#0088AA">selenium</font>, erythrocyte glutathione 
                  peroxidase (GSH-Px) activity, plasma thiol (-SH) and glutathione 
                  (GSH) concentrations along with the assessment of the clinical 
                  stage and surrogate markers of HIV-disease. Design, setting 
                  and subjects: Serum <font color="#0088AA">selenium</font> levels 
                  were determined cross-sectionally in 104 sequentially selected 
                  HIV-infected patients (83 outpatients and 21 patients with ongoing 
                  AIDS defining events). The patients were classified into three 
                  stages of the disease, I, II and III according to the 1993 Centers 
                  For Disease Control (CDC) classification system for HIV-infection. 
                  GSH-Px activities, plasma SH and plasma GSH concentrations were 
                  determined in a subset of 24 patients at stage I and 12 patients 
                  at stage III with an active AIDS-defining disease. Results: 
                  Mean serum <font color="#0088AA">selenium</font> levels were 
                  lower in CDC stage II (68.7 plus or minus 20.9 microg/l; P &lt;0.01; 
                  n=&quot;34)&quot; and stage III (51.4 plus or minus 14.7 microg/l; 
                  P ( 0.01; n=&quot;37)&quot; HIV-infected patients than in healthy 
                  subjects (89.2 plus or minus 20.9 microg/l; n=&quot;72)&quot; 
                  and stage I patients (82.3 plus or minus 20.5; microg/l; n=&quot;33).&quot; 
                  Serum <font color="#0088AA">selenium</font> levels were positively 
                  correlated with CD4-count (r=&quot;0.42;&quot; P &lt; 0.001; 
                  n=&quot;104)&quot; and inversely with levels of soluble tumor 
                  necrosis factor receptors type II (r=&quot;-0.58;&quot; P &lt; 
                  0.01; n=&quot;35),&quot; neopterin (r=&quot;-0.5;&quot; P &lt; 
                  0.001; n=&quot;80)&quot; and beta2-microglobulin (r=&quot;-0.4;&quot; 
                  P &lt; 0.001; n=&quot;94).&quot; Hepatitis C virus (HCV) and 
                  HIV-coinfected patients at CDC stages I and II showed markedly 
                  lower <font color="#0088AA">selenium</font> concentrations compared 
                  to HIV-infected patients without concomitant HCV-infection. 
                  Serum <font color="#0088AA">selenium</font> and GSH-Px activity 
                  in hospitalized AIDS patients was significantly lower as compared 
                  to asymptomatic patients and healthy subjects, whereas plasma 
                  SH and GSH concentrations were lower in both, asymptomatic and 
                  AIDS-patients, than in the controls. Conclusion: The results 
                  show that stages I-III of HIV-disease are characterized by significant 
                  impairments of antioxidative defenses provided by <font color="#0088AA">selenium</font>, 
                  GSH-Px, SH-groups and GSH.</p>
                <p align="center"><a href="./"><img src="../../images/back.gif" alt="back.gif" border="0" width="42" height="10"></a></p>
                <table border="1">
                  <tr> 
                    <td align="center" class="mainfont" height="19"><a href="../">See 
                      More Research</a></td>
                  </tr>
                  <tr> 
                    <td align="center" class="mainfont"><a href="../../minerals/selenium.html">Go 
                      to Ionic Selenium Page</a></td>
                  </tr>
                </table>
                <!-- #EndEditable --> 
              </blockquote>
                  
                
              
                <!-- #BeginLibraryItem "/Library/link_tree.lbi" --><!--#include virtual="/ssi/link_tree.html"--><!-- #EndLibraryItem --><p align="center"><br></p>
		        <blockquote><!-- #BeginLibraryItem "/Library/disclaimer.lbi" --><!--#include virtual="/ssi/disclaimer.html"--><!-- #EndLibraryItem --><!-- #BeginLibraryItem "/Library/copyright.lbi" --><!--#include virtual="/ssi/copyright.html"-->
<hr width="90%">
<!--#include virtual="/ssi/footer_address.html"--><!-- #EndLibraryItem --></blockquote>
</td>
      </tr>
    </table>
    </left></div></td></tr><tr>
	<!--START LEFT SIDE MENU-->
    <td valign="top" width="140" align="left">
	 <table border="0" cellpadding="0" width="140" cellspacing="0">
      <tr>
          <td><!-- #BeginLibraryItem "/Library/navbar.lbi" --><!--#include virtual="/ssi/navbar.html"--><!-- #EndLibraryItem --></td>
      </tr>
    </table>
    </td>
<!--END LEFT SIDE MENU-->
  </tr>
</table>
</body>
<!-- #EndTemplate --></html>
